Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma

Muneyuki Masuda, Masumi Suzui, Ryuji Yasumatu, Torahiko Nakashima, Yuichiro Kuratomi, Kaoru Azuma, Kichinobu Tomita, Sohtaro Komiyama, I. Bernard Weinstein

Research output: Contribution to journalArticle

324 Citations (Scopus)

Abstract

The precise mechanism responsible for the frequent overexpression of cyclin D1 in human head and neck squamous cell carcinoma (HNSCC) is not known. In view of the fact that signal transducers and activators of transcription 3 (Stat3) is often activated in HNSCC cells, we examined the effects of Stat3 on cyclin D1 expression and cell proliferation in the YCU-H891 HNSCC cell line that displays constitutive activation of Stat3. Expression of a dominant negative Stat3 construct in YCU-H891 cells inhibited proliferation, cyclin D1 promoter activity, and cellular levels of cyclin D1 mRNA and protein. The levels of the antiapoptotic Bcl-2 and Bcl-XL proteins were also inhibited. In 51 primary tumor samples from patients with squamous cell carcinoma of the p.o. tongue, there was a significant correlation between increased levels of the activated form of Stat3, phosphorylated-Stat3, and increased levels of cyclin D1 (P < 0.0001). Increased tumor levels of phosphorylated-Stat3 were also associated with lower survival rates (P < 0.01). This study provides the first evidence that in HNSCC, constitutive activation of Stat3 plays a causative role in overexpression of cyclin D1, and in clinical studies, Stat3 activation may provide a novel prognostic factor. Furthermore, agents that target Stat3 may be useful in the treatment of HNSCC.

Original languageEnglish
Pages (from-to)3351-3355
Number of pages5
JournalCancer Research
Volume62
Issue number12
Publication statusPublished - Jun 15 2002

Fingerprint

STAT3 Transcription Factor
Cyclin D1
bcl-X Protein
Cell Proliferation
Carcinoma, squamous cell of head and neck
Tongue
Transcriptional Activation
Squamous Cell Carcinoma
Neoplasms
Survival Rate
Cell Line

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. / Masuda, Muneyuki; Suzui, Masumi; Yasumatu, Ryuji; Nakashima, Torahiko; Kuratomi, Yuichiro; Azuma, Kaoru; Tomita, Kichinobu; Komiyama, Sohtaro; Weinstein, I. Bernard.

In: Cancer Research, Vol. 62, No. 12, 15.06.2002, p. 3351-3355.

Research output: Contribution to journalArticle

Masuda, M, Suzui, M, Yasumatu, R, Nakashima, T, Kuratomi, Y, Azuma, K, Tomita, K, Komiyama, S & Weinstein, IB 2002, 'Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma', Cancer Research, vol. 62, no. 12, pp. 3351-3355.
Masuda, Muneyuki ; Suzui, Masumi ; Yasumatu, Ryuji ; Nakashima, Torahiko ; Kuratomi, Yuichiro ; Azuma, Kaoru ; Tomita, Kichinobu ; Komiyama, Sohtaro ; Weinstein, I. Bernard. / Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. In: Cancer Research. 2002 ; Vol. 62, No. 12. pp. 3351-3355.
@article{4bce2191c5d843aeb2cdd004d5508d74,
title = "Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma",
abstract = "The precise mechanism responsible for the frequent overexpression of cyclin D1 in human head and neck squamous cell carcinoma (HNSCC) is not known. In view of the fact that signal transducers and activators of transcription 3 (Stat3) is often activated in HNSCC cells, we examined the effects of Stat3 on cyclin D1 expression and cell proliferation in the YCU-H891 HNSCC cell line that displays constitutive activation of Stat3. Expression of a dominant negative Stat3 construct in YCU-H891 cells inhibited proliferation, cyclin D1 promoter activity, and cellular levels of cyclin D1 mRNA and protein. The levels of the antiapoptotic Bcl-2 and Bcl-XL proteins were also inhibited. In 51 primary tumor samples from patients with squamous cell carcinoma of the p.o. tongue, there was a significant correlation between increased levels of the activated form of Stat3, phosphorylated-Stat3, and increased levels of cyclin D1 (P < 0.0001). Increased tumor levels of phosphorylated-Stat3 were also associated with lower survival rates (P < 0.01). This study provides the first evidence that in HNSCC, constitutive activation of Stat3 plays a causative role in overexpression of cyclin D1, and in clinical studies, Stat3 activation may provide a novel prognostic factor. Furthermore, agents that target Stat3 may be useful in the treatment of HNSCC.",
author = "Muneyuki Masuda and Masumi Suzui and Ryuji Yasumatu and Torahiko Nakashima and Yuichiro Kuratomi and Kaoru Azuma and Kichinobu Tomita and Sohtaro Komiyama and Weinstein, {I. Bernard}",
year = "2002",
month = "6",
day = "15",
language = "English",
volume = "62",
pages = "3351--3355",
journal = "Cancer Research",
issn = "0008-5472",
number = "12",

}

TY - JOUR

T1 - Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma

AU - Masuda, Muneyuki

AU - Suzui, Masumi

AU - Yasumatu, Ryuji

AU - Nakashima, Torahiko

AU - Kuratomi, Yuichiro

AU - Azuma, Kaoru

AU - Tomita, Kichinobu

AU - Komiyama, Sohtaro

AU - Weinstein, I. Bernard

PY - 2002/6/15

Y1 - 2002/6/15

N2 - The precise mechanism responsible for the frequent overexpression of cyclin D1 in human head and neck squamous cell carcinoma (HNSCC) is not known. In view of the fact that signal transducers and activators of transcription 3 (Stat3) is often activated in HNSCC cells, we examined the effects of Stat3 on cyclin D1 expression and cell proliferation in the YCU-H891 HNSCC cell line that displays constitutive activation of Stat3. Expression of a dominant negative Stat3 construct in YCU-H891 cells inhibited proliferation, cyclin D1 promoter activity, and cellular levels of cyclin D1 mRNA and protein. The levels of the antiapoptotic Bcl-2 and Bcl-XL proteins were also inhibited. In 51 primary tumor samples from patients with squamous cell carcinoma of the p.o. tongue, there was a significant correlation between increased levels of the activated form of Stat3, phosphorylated-Stat3, and increased levels of cyclin D1 (P < 0.0001). Increased tumor levels of phosphorylated-Stat3 were also associated with lower survival rates (P < 0.01). This study provides the first evidence that in HNSCC, constitutive activation of Stat3 plays a causative role in overexpression of cyclin D1, and in clinical studies, Stat3 activation may provide a novel prognostic factor. Furthermore, agents that target Stat3 may be useful in the treatment of HNSCC.

AB - The precise mechanism responsible for the frequent overexpression of cyclin D1 in human head and neck squamous cell carcinoma (HNSCC) is not known. In view of the fact that signal transducers and activators of transcription 3 (Stat3) is often activated in HNSCC cells, we examined the effects of Stat3 on cyclin D1 expression and cell proliferation in the YCU-H891 HNSCC cell line that displays constitutive activation of Stat3. Expression of a dominant negative Stat3 construct in YCU-H891 cells inhibited proliferation, cyclin D1 promoter activity, and cellular levels of cyclin D1 mRNA and protein. The levels of the antiapoptotic Bcl-2 and Bcl-XL proteins were also inhibited. In 51 primary tumor samples from patients with squamous cell carcinoma of the p.o. tongue, there was a significant correlation between increased levels of the activated form of Stat3, phosphorylated-Stat3, and increased levels of cyclin D1 (P < 0.0001). Increased tumor levels of phosphorylated-Stat3 were also associated with lower survival rates (P < 0.01). This study provides the first evidence that in HNSCC, constitutive activation of Stat3 plays a causative role in overexpression of cyclin D1, and in clinical studies, Stat3 activation may provide a novel prognostic factor. Furthermore, agents that target Stat3 may be useful in the treatment of HNSCC.

UR - http://www.scopus.com/inward/record.url?scp=0037096876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037096876&partnerID=8YFLogxK

M3 - Article

C2 - 12067972

AN - SCOPUS:0037096876

VL - 62

SP - 3351

EP - 3355

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 12

ER -